Index Identifies 5 Industry Leaders
| 1. | GlaxoSmithKline | (U.K.) |
| 2. | Novo Nordisk | (Denmark) |
| 3. | Merck & Co. | (NJ, USA) |
| 4. | Novartis | (Switzerland) |
| 5. | Sanofi-Aventis | (France) |
|
NAIROBI ACCESS TO MEDICINE INDEX WORKSHOP February 16th and 17th, a large group of members of non-governmental organizations based in Africa, Asia and South America, working in the field of access to medicine and health issues, came together in Nairobi, Kenya, to discuss the Access to Medicine Index. more >
|
 “We can expand the report-card idea beyond the pharmaceutical industry and make sure the rankings get publicity so companies get credit for doing good work.” (Time, July 31, 2008)
Bill Gates, Chair, Microsoft Corporation
Co-Chair, Bill and Melinda Gates Foundation.
 “I've been impressed by the ATM Index. It presents well-balanced stakeholder views on good practices for the pharmaceutical industry and it provides clear standards against which the performance of individual companies can be judged.”
Mary Robinson, United Nations High Commissioner for Human Rights (1997-2002), fmr. President of Ireland.
“When I talk to executives from pharmaceutical companies, they tell me that they want to do more for neglected diseases — but they at least need to get credit for it. [The Access to Medicine Index] does exactly that.” (Time, July 31, 2008)
Bill Gates, Chair, Microsoft Corporation
Co-Chair, Bill and Melinda Gates Foundation.
 “The Access to Medicine Index has proven to provide much-needed transparency into pharmaceutical industry actions and policies. That will ultimately lead to greater access to healthcare for millions of people all over the globe.”
Herman Wijffels, Executive Director, World Bank, Washington, DC, frm. Chair, Rabobank.
|
Global Investors Support Index Sixteen institutional investors, together managing more than USD 1500 billion in assets, have signed an Investor Statement highlighting their interest in the Access to Medicine Index.
Major investors like Morley and Henderson Global Investors say the Index “may be useful to assess the long-term value of pharmaceutical companies.” more >
|
Drug Makers Differ on Policies for Poor The Access to Medicine Index demonstrates how major pharmaceutical companies differ strongly in their efforts to provide people in low-income countries with affordable drugs, diagnostics and vaccines.
The Index, launched June 16, presents detailed rankings and profiles of twenty of the world’s largest makers of pharmaceuticals. more >
|
We Welcome Your Feedback The Access to Medicine Index seeks full transparency towards all who are dedicated to the cause of improving access to medicine. We very much welcome your feedback on the Access to Medicine Index itself, on this new website and on the information the website contains.
Please use our feedback form to send us your questions or comments.
|
|
|
